Inventor · disambiguated record
Anat Cohen-Dayag
Also filed as: COHEN-DAYAG ANAT
7 granted patents·13 pending applications·38 citations·filing 2006–2022
85Inventor score
Top patents by PatentIndex Score
20 records- 0190US7741433B2Diagnostic markers, especially for in vivo imaging and assays and methods of use thereofCOMPUGEN LTD·Filed 2007·Granted Jun 22, 2010·7 cites·16 claims
- 0289US7488813B2Diagnostic markers, especially for in vivo imaging, and assays and methods of use thereofCOMPUGEN LTD·Filed 2006·Granted Feb 10, 2009·12 cites·2 claims
- 0385US8415455B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2008·Granted Apr 9, 2013·9 cites·14 claims
- 0484US9107862B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Aug 18, 2015·5 cites·9 claims
- 0581US9375466B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Jun 28, 2016·3 cites·4 claims
- 0674US9555087B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2014·Granted Jan 31, 2017·1 cites·27 claims
- 0773US10098934B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Oct 16, 2018·1 cites·9 claims
- 0869US2011311450A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2009·Application pending·0 cites
- 0963US2018298109A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2018·Application pending·0 cites
- 1058US2017037141A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 1157US2011052501A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsDASSA LIAT·Filed 2009·Application pending·0 cites
- 1257US2024082397A1Anti-pvrig antibodies formulations and uses thereofCOMPUGEN LTD·Filed 2022·Application pending·0 cites
- 1356US2010189652A1Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereofCOMPUGEN LTD·Filed 2010·Application pending·0 cites
- 1456US2016068606A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2015·Application pending·0 cites
- 1555US2017107284A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 1654US2024076373A1Combination therapy with anti-pvrig antibodies formulations and anti-pd-1 antibodiesCOMPUGEN LTD·Filed 2022·Application pending·0 cites
- 1752US2016177395A1Biomarkers for the prediction of renal injuryCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 1849US2013315819A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Application pending·0 cites
- 1946US2022378742A1Combination therapy with anti-pvrig antibodies formulations and anti-pd-1 antibodiesCOMPUGEN LTD·Filed 2020·Application pending·0 cites
- 2044US2011003708A1Biomarkers for the prediction of renal injuryCOMPUGEN LTD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anat Cohen-Dayag files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →